Somatic mutations in myeloid cell leukemia-1 contribute to the pathogenesis of glioma by prolonging its half-life

Molecular Medicine Reports
Xiupeng LvYinghui Xu

Abstract

The identification of mutated genes in glioblastoma multiforme (GBM) is an essential step towards improving current understanding of the molecular mechanism underlying the disease and establishing novel targets for diagnostic and therapeutic purposes. The present study used direct sequencing to screen 20 malignancy-associated genes, which have either been well described in the literature or observed multiple times in human cancer sequencing, in cancerous and normal control tissue samples from 20 patients with histologically confirmed GBM. The investigation identified five somatic non-synonymous coding mutations in four candidate genes, with two located in the proline, glutamic acid, serine, threonine-rich region of myeloid cell leukemia sequence 1 (Mcl)-1, (D155G and L174S). The sample pool was then expanded by sequencing Mcl-1 in a further 43 patients with GBM and another somatic mutation in the same region, D155H, was identified. The subsequent functional investigation confirmed that these somatic mutations affected the degradation of Mcl-1, and the growth of glioma cells transfected with mutant plasmids was significantly accelerated compared with cells overexpressing wild-type Mcl-1. The mutational profiling of GBM in the pr...Continue Reading

References

Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K M KozopasR W Craig
Sep 12, 2002·The Journal of Biological Chemistry·Seiji InoshitaHidenori Ichijo
Dec 12, 2003·Nature·Joseph T OpfermanStanley J Korsmeyer
May 19, 2004·British Journal of Haematology·John G ClohessyHugh J M Brady
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christiane ThallingerEdgar Selzer
Aug 3, 2004·Nature Medicine·Bert Vogelstein, Kenneth W Kinzler
Oct 12, 2004·The International Journal of Biochemistry & Cell Biology·Jorg MichelsGraham Packham
Nov 20, 2004·The Journal of Biological Chemistry·Catherine L DayMark G Hinds
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 9, 2006·Science·Tobias SjöblomVictor E Velculescu
Mar 9, 2007·Nature·Christopher GreenmanMichael R Stratton
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Oct 13, 2007·Science·Laura D WoodBert Vogelstein
Nov 17, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michael E ScheurerMelissa L Bondy
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
May 13, 2009·Molecular and Cellular Biology·Caroline MorelRoger J Davis
Oct 21, 2014·Cancers·Derek J Erstad, James C Cusack
Jan 2, 2015·Journal of Cancer·Anna Di LonardoSimonetta Pulciani

❮ Previous
Next ❯

Citations

Dec 15, 2020·Journal of Hematology & Oncology·Arnold BolomskyJo Caers
Aug 3, 2021·International Journal of Biological Macromolecules·Pooja MittalIndrakant Kumar Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.